Phibro Animal Health (PAHC) FY2017 results: revenue $764 million, up 1.7% on the year
Phibro Animal Health Corp. (PAHC) reported revenue of $764 million for fiscal 2017, the year ended 30 June 2017, up 1.7% on the year before. Net income was $65 million, down 21.9%, and diluted earnings per share $1.61. The figures are the company's own, from the 10-K it filed with the SEC on 30 August 2017.
Revenue
$764 million
+1.7% on the year
FY2012FY2017
Operating margin
12.8%
11.4% a year earlier
FY2012FY2017
Net income
$65 million
-21.9% on the year
FY2012FY2017
Diluted EPS
$1.61
-22.2% on the year
FY2012FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
764
752
749
+1.7%
Cost of revenue
516
512
515
+0.7%
Gross profit
248
239
233
+3.9%
Gross margin
32.5%
31.8%
31.2%
Research and development
9.4
11.0
9.5
-14.4%
Selling, general and administrative
150
153
146
-1.9%
Operating income
97.9
85.7
87.7
+14.2%
Operating margin
12.8%
11.4%
11.7%
Interest expense
16.9
16.8
14.6
+0.1%
Pre-tax income
80.5
76.8
78.8
+4.9%
Income tax
15.9
-6.0
18.5
Effective tax rate
19.8%
-7.8%
23.5%
Net income
64.6
82.7
60.3
-21.9%
Net margin
8.5%
11.0%
8.1%
Diluted EPS
$1.61
$2.07
$1.51
-22.2%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
98.4
37.2
68.7
+164.3%
Capital expenditure
20.9
36.4
20.1
-42.6%
Free cash flow
77.5
0.9
48.6
+8,849.8%
Free cash flow margin
10.1%
0.1%
6.5%
Cash from investing
-21.9
-82.8
n/a
Cash from financing
-53.7
50.4
n/a
Depreciation and amortisation
26.0
23.5
21.6
+10.9%
Share-based compensation
0.0
n/a
n/a
Dividends paid
15.8
15.7
15.6
+0.8%
Dividend per share
$0.40
$0.40
$0.40
0.0%
Diluted shares, weighted
40m
40m
40m
+0.2%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
151
90.5
29.6
+67.1%
Deposits
n/a
-6.0
-0.5
Debt
313
350
290
-10.6%
Other liabilities
159
173
175
-8.1%
Total liabilities and equity
623
608
493
+2.6%
Fixed assets
127
127
104
+0.0%
Goodwill
24.0
21.1
12.6
+13.5%
Intangible assets
54.6
60.1
37.3
-9.1%
Cash and equivalents
56.1
33.6
29.2
+66.9%
Receivables
126
124
111
+1.7%
Inventory
161
168
150
-3.9%
Other assets
74.3
74.2
48.9
+0.1%
Total assets
623
608
493
+2.6%
10-K for the year ended 30 June 2017, filed 30 August 2017: the filing.